论文部分内容阅读
目的:文章通过分析16个省级基本药物增补目录的药品收录情况,旨在为各省(区、市)合理制定省级增补目录和完善国家基本药物目录提供参考。方法:采用描述性分析法,总结省级增补目录在药品收录方面的特点与差异。结果:不同地区收录的药品数量和种类差异较大,东部地区增补的药品种类最多,中部地区次之,西部地区最少;各地增补药品目录以收录心血管系统用药、激素和内分泌系统用药、消化系统用药和血液系统用药等慢性病治疗药物为主;由于疾病谱和用药习惯不同,各地增补目录的药品重合性不高。结论:制定省级基本药物增补目录可缓解国家基本药物目录“不够用”的问题,但应适当控制省级基本药物的增补数量;对于重合性较高的省级基本药物可考虑收录到国家基本药物目录中;要进一步完善国家基本药物制度,使省级基本药物增补目录发挥应有作用。
Aims: This article aims to provide a reference for provincial (autonomous regions and municipalities) to rationally make provincial supplementary catalogs and improve the national essential medicines catalog by analyzing the contents of medicines included in the 16 provincial basic medicines supplementary catalogs. Methods: Descriptive analysis was used to summarize the characteristics and differences of provincial supplementary catalogs in the aspects of medicine collection. Results: The quantity and type of drugs included in different regions were quite different. The types of drugs added in the eastern region were the highest, followed by the central region and the western region at the least. The catalogs of drugs were added to each area to include cardiovascular system drugs, hormone and endocrine system drugs, digestive system Drugs and drugs for the treatment of chronic diseases such as blood system-based; due to disease spectrum and medication habits, supplements around the directory supplement drugs is not high. Conclusion: The establishment of the Provincial Supplementary Essential Medicines List can alleviate the problem of “insufficient use” of the national essential medicines list, but the supplementary quantities of the provincial basic medicines should be appropriately controlled. For provincial basic medicines with higher coincidence, the inclusion of National Essential Drugs Catalog; to further improve the national essential medicines system, so that provincial essential medicines supplement directory to play its due role.